Repair of Nasal Valve Compromise
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.210 alerts
Get alerted when Policy CP.MP.210 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity guidelines for repair of nasal valve compromise (NVC) for members of Arizona Complete Health / Centene-affiliated health plans; describes covered indications, non-covered procedures, and supporting coding guidance.
No material clinical or coverage changes in this revision.
Coverage Criteria for Repair of Nasal Valve Compromise
Medically Necessary Repair Criteria
Covered when ALL of the following are met
The policy identifies specific procedures for which safety and efficacy have not been established for repair of nasal vestibular stenosis. These procedures include: radiofrequency ablation (VivAer®), absorbable lateral wall implants (Latera®), and nasal valve suspension surgery. The document notes that evidence for VivAer consists of a small number of low-quality studies that suggest the procedure may be safe and can improve patient-reported symptoms, but the evidence is limited and does not clearly demonstrate improvements in objective measures or comparisons to active treatments. For Latera®, the policy describes the device and its absorbable implant mechanism but does not find established safety and efficacy for repair of nasal vestibular stenosis. Because the available data are insufficient, these procedures are listed as not established for this indication and therefore are excluded from coverage under this policy.
Providers should be aware that these exclusions reflect the policy judgment that current evidence does not support routine coverage for these techniques when used to repair nasal vestibular stenosis. When considering treatment options, clinicians should document the rationale for selecting alternative therapies and ensure that all other coverage criteria (clinical findings, symptom correlation, exclusion of other causes, and trial of conservative therapy) have been met before pursuing surgical repair avenues that are supported by the policy.
This policy explicitly states that use of CPT 30468 (repair of nasal valve collapse with subcutaneous/submucosal lateral wall implant[s]) and CPT 30469 (repair of nasal valve collapse with low energy, temperature-controlled radiofrequency subcutaneous/submucosal remodeling) is not supported and therefore not covered for this indication. These code designations align with the policy conclusion that absorbable implants (e.g., Latera®) and low-energy radiofrequency procedures (e.g., VivAer®) lack established safety and efficacy for repair of nasal vestibular stenosis.
By contrast, the policy lists CPT 30465 (repair of nasal vestibular stenosis, e.g., spreader grafting or lateral nasal wall reconstruction) as the procedure code that supports coverage when the medical necessity criteria are met. Prior authorization is required for repair procedures, and documentation should confirm that all clinical criteria and conservative therapy requirements described in the policy have been satisfied before approving CPT 30465.
Coding
| 30465 | Repair of nasal vestibular stenosis (e.g., spreader grafting, lateral nasal wall reconstruction) |
Provider Actions, Authorization, and Documentation Requirements
Conservative Therapy Requirement
A trial of conservative therapy is required prior to consideration of surgical repair. Conservative modalities include nasal cones, external nasal dilator adhesive strips (e.g., Breathe Right®), a six-week trial of nasal steroids, or outpatient nocturnal trial of nasal dilators (e.g., Max-Air Nose Cones®, Sinus Cones®).
- Conservative treatments: nasal cones, external nasal dilator strips, nasal dilators (Max-Air, Sinus Cones), six-week trial of nasal steroids
Denial Risk for Not Meeting Criteria
Procedures that do not meet the listed medical necessity criteria (A–D) may be denied. Ensure documentation shows clinical findings, symptom detail, results of Cottle maneuver or equivalent, exclusion of other causes of obstruction, and evidence of an adequate trial of conservative therapy.
- Risk of denial when criteria A–D are not satisfied
- Document: clinical history, symptom details, physical exam findings, Cottle maneuver or equivalent, prior conservative treatments and results
Required Documentation to Support Medical Necessity
Provide complete documentation to support medical necessity: clinical history (onset, laterality, triggers), symptom severity (e.g., NOSE score), physical exam findings (internal/external valve collapse), positive response to Cottle or Bachman maneuvers, objective testing when available (rhinomanometry, acoustic rhinometry, endoscopy, CT if indicated), and specifics of prior conservative treatments and outcomes.
- Clinical history including duration, laterality, and triggers
- Symptom measures (e.g., NOSE score) and exam findings demonstrating valve compromise
- Positive response to Cottle or Bachman maneuver
- Objective testing if performed: rhinomanometry, acoustic rhinometry, nasal endoscopy, CT
- Details and duration of conservative therapy and results
Background
Nasal valve compromise (NVC), also referred to as nasal valve collapse, is a narrowing of the nasal passage that produces obstructed nasal breathing. Anatomically, NVC can involve the internal valve (upper lateral cartilage and its relationship to the septum) or the external valve (support of the lower lateral cartilage); collapse or weakness of these structures increases airflow resistance and impairs inhalation.
Common causes of NVC include prior nasal surgery or trauma that weakens cartilage support, intrinsic structural or congenital defects, inflammatory conditions, and age-related tissue laxity. Symptoms often vary with position and environmental exposures and may be unilateral. Diagnosis relies on correlation of clinical findings (e.g., internal or external valve collapse) with symptom improvement on maneuvers such as the Cottle maneuver or lateralization of the upper lateral cartilage, and exclusion of other causes of nasal obstruction.
Management typically begins with conservative measures—external nasal dilators, nasal cones, or a trial of topical nasal steroids—and only when symptoms persist despite these measures and objective findings align with symptom relief on physical maneuvers should surgical repair be considered per the policy criteria.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.